The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: combivent     Quarter: 2016Q3

Total Drug/Injury Combinations: 279     Number of Pages: 14

DRUGNAME PT EventCount
COMBIVENT RESPIMAT Nasal congestion 1 view events
COMBIVENT RESPIMAT Nervousness 1 view events
COMBIVENT RESPIMAT Ophthalmic herpes zoster 1 view events
COMBIVENT RESPIMAT Oxygen consumption decreased 1 view events
COMBIVENT RESPIMAT Palpitations 1 view events
COMBIVENT RESPIMAT Paraesthesia 1 view events
COMBIVENT RESPIMAT Petechiae 1 view events
COMBIVENT RESPIMAT Pneumonia 1 view events
COMBIVENT RESPIMAT Product packaging quantity issue 1 view events
COMBIVENT RESPIMAT Rash macular 1 view events
COMBIVENT RESPIMAT Skin atrophy 1 view events
COMBIVENT RESPIMAT Skin discolouration 1 view events
COMBIVENT RESPIMAT Sputum discoloured 1 view events
COMBIVENT RESPIMAT Squamous cell carcinoma 1 view events
COMBIVENT RESPIMAT Swelling face 1 view events
COMBIVENT RESPIMAT Thyroid disorder 1 view events
COMBIVENT RESPIMAT Vision blurred 1 view events
COMBIVENT RESPIMAT Visual impairment 1 view events
COMBIVENT RESPIMAT Wheezing 1 view events

Total Drug/Injury Combinations: 279     Number of Pages: 14

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)